Sort
30,917 grants matching “tumor microenvironment”
Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
$678,000Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · U19 · FY2023 · AI
Modulation of Therapeutic Response
$677,808James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Aire-expressing macrophages as novel mediators of tumor immune evasion
$677,787James Morgan Gardner · University Of California, San Francisco · R37 · FY2025 · CA
Early detection and risk of head and neck cancer through immune based spatial omics
$677,643Sara Isabel Pai · Yale University · U01 · FY2025 · DE
Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancer
$677,533Sam C. Wang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Development of novel human Fab probes for PET imaging of macrophages
$677,520Bernadette Marquez-Nostra · Yale University · R01 · FY2022 · EB
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$677,471Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2020 · CA
Three-dimensional Scaffold-based Systems for Primary Human Intestinal Culture
$677,466Calvin J Kuo · Stanford University · R01 · FY2013 · DK
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$677,442Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2021 · CA
Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma
$677,362Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Interstitial Chemophototherapy as an Intervention in Locally Advanced Pancreatic Cancer
$677,176Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2025 · CA
Project 4: MPN-RC Clinical Consortium
$677,170John Mascarenhas · Icahn School Of Medicine At Mount Sinai · P01 · FY2019 · CA
Targeting the CD73-adenosinergic pathway in head and neck cancer
$677,163Yan Cui · Augusta University · R01 · FY2025 · DE
Probiotic guided CAR-T therapy (ProCARs) for breast cancer
$676,866Tal Danino · Columbia Univ New York Morningside · R01 · FY2022 · EB
Translational, statistical, and clinical trials core
$676,826Julie R Park · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
$676,757Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Tumor Microenvironment in Cancer Progression
$676,757Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Applying Optical Approaches to the Drug Delivery Problem
$676,652Martin Schnermann · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Decoding the co-evolution of cancer subclones and their ecosystem in TNBC multi-organ metastasis
$676,584Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Systematic Testing of a TGFβ Targeted Theranostic in Preclinical Cancer
$676,567Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2025 · CA
Interrogating the Role of Bacterial Methyl-modifying Enzymes in Pathoadaptation and Host Epigenetic Interference in Cancer
$676,366Christopher D Johnston · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$676,329Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2020 · CA
Defining immune-evasive mechanical signaling in head and neck cancer
$676,314Xaralabos Varelas · Boston University Medical Campus · R01 · FY2025 · DE
Targeted radiation and immunocytokine therapy for CEA positive malignancies
$676,263John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Targeted radiation and immunocytokine therapy for CEA positive malignancies
$676,263John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA